We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > CMV

News List

FDA Approves Takeda’s LIVTENCITY as the First and Only Treatment for Post-Transplant Cytomegalovirus AmericanPharmaceuticalReview
December 01, 2021
Takeda Pharmaceutical Company Limited announced that the FDA has approved LIVTENCITY (maribavir) for the treatment of adults and pediatric patients (12 years of age or older and weighing at least 35 kg) ...
U.S. Food & Drug Administration Grants Priority Review of Maribavir americanpharmaceuticalreview
May 24, 2021
Takeda Pharmaceutical Company Limited announced that the U.S. Food & Drug Administration (FDA) has accepted a New Drug Application (NDA) for maribavir for the treatment of CMV infection in those that are refractory with or without resistance (R/R) ...
NASA calls for new vaccinations to combat virus reactivation during spaceflight pharmaceutical-technology
March 19, 2019
Researchers from NASA’s Johnson Space Center have discovered that dormant herpes viruses reactivate during spaceflight, leading to an urgent need to develop counter-measures, including vaccination, to ensure the success of deep-space missions.